Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-10-077417
Filing Date
2010-08-13
Accepted
2010-08-13 17:09:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w79559ae8vk.htm 425 37350
2 EX-2.1 w79559aexv2w1.htm EX-2.1 376432
3 EX-10.1 w79559aexv10w1.htm EX-10.1 87696
4 EX-10.2 w79559aexv10w2.htm EX-10.2 88345
5 EX-10.3 w79559aexv10w3.htm EX-10.3 51693
  Complete submission text file 0000950123-10-077417.txt   643481
Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Subject) CIK: 0001298521 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33054 | Film No.: 101016151
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filed by) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations